Russian Heart Failure Journal 2009year Asymptomatic form of atrial fibrillation


To access this material please log in or register

Register Authorize
2009/

Asymptomatic form of atrial fibrillation

Tatarsky B.A., Popov S.V., Antonchenko I.V., Tatarsky R.B., Kazenova N.V.

Keywords:

DOI:

Many investigators have confirmed that atrial fibrillation (AF) is completely asymptomatic in some patients. The article presents available at this moment data on prevalence of the asymptomatic form of AF, methods of its detection, predictive significance and treatment.
  1. Feinberg WM, Blackshear JL, Laupacis A et al. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med. 1995; 155 (5):469‑473.
  2. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol. 1998; 82 (8A):2N-9N.
  3. Go AS, Hylek EM, Phillips KA et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001; 285 (18):2370–2375.
  4. Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol. 2003; 91 (6A):2D-8D
  5. Сулимов В. А. Медикаментозная терапия фибрилляции предсердий: настоящее и будущее. Кардиология. 1999; 39 (7):69–75.
  6. Lloyd-Jones DM, Wang TJ, Leip EP et al. Lifetime risk for development of atrial fibrillation: the Framingham heart study. Circulation. 2004; 110 (9):1042–1046.
  7. Prystowsky E, Katz A. Atrial Fibrillation in Textbook of Cardiovascular Medicine. Philadelphia: Lippincott-Raven, 1998:1661.
  8. Lüderitz B, Jung W. Quality of life in patients with atrial fibrillation. Arch Intern Med. 2000 Jun 26; 160 (12):1749–1757.
  9. Татарский Б. А., Чирейкин Л. В. Тактика ведения больных с фибрилляцией предсердий. Вестник аритмологии.1999; 12:5–20.
  10. Miller JM, Zipes DP. Management of the patient with cardiac arrhithmias. In Braunwald E, Zipes D, Libby P. (eds). Heart disease. A textbook of cardiovascular medicine. Philadelphia: W. B. Saunders company. 2001. P. 731‑736
  11. Татарский Б. А. Бессимптомная форма фибрилляции предсердий. Сердечная недостаточность.2002; 1 (5):217‑221.
  12. Benjamin EJ, Wolf PA, D’Agostino RB et al. Impact of atrial fibrillation on the risk of death: the Framingham heart study. Circulation. 1998; 98 (10):946‑952.
  13. Benjamin EJ, Levy D, Vaziri SM et al. Independent riak factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994; 271 (11):840‑844.
  14. Dietz A, Walter J, Bracharz H et al. Cardiac arrhythmias in active elderly persons--age dependence of heart rate and arrhythmias. Z Kardiol. 1987; 76 (2):86–94.
  15. Kinlay S, Leitch JW, Neil A et al. Cardiac event recorders yield more diagnoses and are more cost-effective than 48‑hour Holter monitoring in patients with palpitations. A controlled clinical trial. Ann Intern Med. 1996; 124 (1 Pt 1):16–20.
  16. FeFetsch T, Bauer P, Engberding R et al. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial. Eur Heart J. 2004; 25 (16):1385–1394.
  17. Kerr C, Boone J, Connolly S et al. Follow-up of atrial fibrillation: The initial experience of the Canadian Registry of Atrial Fibrillation. Eur Heart J. 1996; 17 (Suppl C):48–51.
  18. Frishman WH, Heiman M, Karpenos A et al. Twenty-four-hour ambulatory electrocardiography in elderly subjects: prevalence of various arrhythmias and prognostic implications (report from the Bronx Longitudinal Aging Study). Am Heart J. 1996; 132 (2 Pt 1):297‑302.
  19. Lévy S, Maarek M, Coumel P et al. Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists. Circulation. 1999; 99 (23):3028–3035.
  20. Page RL, Wilkinson WE, Clair WK et al. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation. 1994; 89 (1):224‑227.
  21. Steven D, Rostock T, Lutomsky B et al. What is the real atrial fibrillation burden after catheter ablation of atrial fibrillation? A prospective rhythm analysis in pacemaker patients with continuous atrial monitoring. Eur Heart J. 2008; 29 (8):1037–1042.
  22. Kulbertus H, de Leval-Rutten F, Bartsch P et al. Atrial fibrillation in elderly, ambulatory patients. In: Kulbertus H, Olsson S, Schlepper M eds. Atrial fibrillation. Moelndal. AB Haessle. 1982:148‑157.
  23. Defaye P, Dournaux F, Mouton E. Prevalence of supraventricular arrhythmias from the automated analysis of data stored in the DDD pacemakers of 617 patients: The AIDA study. The AIDA Multicenter Study Group. Automatic Interpretation for Diagnosis Assistance. Pacing Clin Electrophysiol. 1998; 21 (1 Pt 2):250‑255.
  24. Israel CW, Grönefeld G, Ehrlich JR et al. Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device. J Am Coll Cardiol. 2004; 43 (1):47–52.
  25. Page RL, Tilsch TW, Connolly SJ et al. Asymptomatic or «silent» atrial fibrillation: Frequency in untreated patients and patients receiving azimilide. Circulation. 2003; 107 (8):1141–1145.
  26. Haissaguerre M, Jais P, Shah D et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998; 339 (10):659‑666.
  27. Nademanee K, McKenzie J, Kosar E et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol. 2004; 43 (11):2044–2053.
  28. Willems S, Klemm H, Rostock T et al. Substrate modification combined with pulmonary vein isolation improves outcome of catheter ablation in patients with persistent atrial fibrillation: a prospective randomized comparison. Eur Heart J. 2006; 27 (23):2871–2878.
  29. Haïssaguerre M, Jaïs P, Shah DC et al. Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation. 2000; 101 (12):1409–1417.
  30. Piorkowski C, Kottkamp H, Tanner H et al. Value of different follow-up strategies to assess the efficacy of circumferential pulmonary vein ablation for the curative treatment of atrial fibrillation. J Cardiovasc Electrophysiol. 2005; 16 (12):1286–1292.
  31. Kottkamp H, Tanner H, Kobza R et al. Time courses and quantitative analysis of atrial fibrillation episode number and duration after circular plus linear left atrial lesions: trigger elimination or substrate modification: early or delayed cure? J Am Coll Cardiol. 2004; 44 (4):869‑877.
  32. Vasamreddy CR, Dalal D, Dong J et al. Symptomatic and asymptomatic atrial fibrillation in patients undergoing radiofrequency catheter ablation. J Cardiovasc Electrophysiol. 2006; 17 (2):134‑139.
  33. Klemm HU, Ventura R, Rostock T et al. Correlation of symptoms to ECG diagnosis following atrial fibrillation ablation. J Cardiovasc Electrophysiol. 2006; 17 (2):146‑150.
  34. Hindricks G, Piorkowski C, Tanner H et al. Perception of atrial fibrillation before and after radiofrequency catheter ablation: Relevance of asymptomatic arrhythmia recurrence. Circulation. 2005; 112 (3):307‑313.
  35. Neumann T, Erdogan A, Dill T et al. Asymptomatic recurrences of atrial fibrillation after pulmonary vein isolation. Europace. 2006; 8 (7):495‑498.
  36. Gerstenfeld EP, Guerra P, Sparks PB et al. Clinical outcome after radiofrequency catheter ablation of focal atrial fibrillation triggers. J Cardiovasc Electrophysiol. 2001; 12 (8):900‑908.
  37. Berkowitsch A, Neumann T, Kurzidim K et al. Comparison of generic health survey SF-36 and arrhythmia related symptom severity check list in relation to post-ablation recurrence. Europace. 2003; 5 (4):351‑355.
  38. Furberg CD, Psaty BM, Manolio TA et al. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol. 1994; 74 (3):236‑241.
  39. Fuster V, Rydén LE, Cannom DS et al. ACC / AHA / ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology / American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace. 2006; 8 (9):651‑745.
  40. Ratcliffe PJ, Wilcock GK. Cerebrovascular disease in dementia: the impotance of atrial fibrillation. Postgrad Med J. 1985; 61 (713):201‑204.
  41. Kempster PA, Gerraty RP, Gates PC. Asymptomatic cerebral infarction in patients with chronic atrial fibrillation. Stroke. 1988; 19 (8):955‑957.
  42. Feinberg WM, Seeger JF, Carmody RF et al. Epidemiologic features of asymptomatic cerebral infarction in patients with nonvalvular atrial fibrillation. Arch Intern Med. 1990; 150 (11):2340–2344.
  43. Petersen P, Pedersen F, Madsen EB et al. Echocardiography and cerebral computed tomography in chronic atrial fibrillation. Eur Heart J. 1989; 10 (12):1101–1104.
  44. Cullinane M, Wainwright R, Brown A et al. Asymptomatic embolization in subjects with atrial fibrillation not taking anticoagulants: a prospective study. Stroke. 1998; 29 (9):1810–1815.
  45. Farina E, Magni E, Ambrosini F et al. Neuropsychological deficits in asymptomatic atrial fibrillation. Acta Neurol Scand. 1997; 96 (5):310‑316.
  46. Ott A, Breteler MM, de Bruyne MC et al. Atrial fibrillation and dementia in a population-based study: the Rotterdam Study. Stroke. 1997; 28 (2):316‑321.
  47. Lavy S, Stern S, Melamed E et al. Effect of chronic atrial fibrillation on regional cerebral blood flow. Stroke. 1980; 11 (1):35–38.
  48. Wyse DG, Waldo AL, DiMarco JP et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002; 347 (23):1825–1833.
  49. Van Gelder IC, Hagens VE, Bosker HA et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med. 2002; 347 (23):1834–1840.
  50. Falcone RA, Morady F, Armstrong WF. Transesophageal echocardiographic evaluation of left atrial appendage function and spontaneous contrast formation after chemical or electrical cardioversion of atrial fibrillation. Am J Cardiol. 1996; 78 (4):435‑439.
  51. Grimm RA, Leung DY, Black IW et al. Left atrial appendage «stunning» after spontaneous conversion of atrial fibrillation demonstrated by transesophageal Doppler echocardiography. Am Heart J. 1995; 130 (1):174‑176.
  52. Arnold AZ, Mick MJ, Mazurek RP et al. Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter. J Am Coll Cardiol. 1992; 19 (4):851‑855.

To access this material please log in or register

Register Authorize
Ru En